Candidate-gene analysis of white matter hyperintensities on neuroimaging The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters

Background White matter hyperintensities (WMH) are a common radiographic fi nding and may be a useful endophenotype for small vessel diseases. Given high heritability of WMH, we hypothesised that certain genotypes may predispose individuals to these lesions and consequently, to an increased risk of stroke, dementia and death. We performed a meta-analysis of studies investigating candidate genes and WMH to elucidate the genetic susceptibility to WMH and tested associated variants in a new independent WMH cohort. We assessed a causal relationship of WMH to methylene tetrahydrofolate reductase (MTHFR). Methods studies investigating candidate genes in WMH were assessed. Associated variants were tested in a new independent ischaemic cohort of 1202 WMH patients. Mendelian randomization was undertaken to assess a causal relationship between WMH and MTHFR. interrogating eight polymorphisms in seven genes covering 6,314 WMH cases and 15,461 controls. Fixed-effects meta-analysis that the C-allele containing genotypes of the aldosterone synthase CYP11B2 T( − 344)C gene polymorphism were associated with a decreased risk of WMH (OR=0.61; 95% CI, 0.44 to 0.84; p=0.003). Using mendelian randomisation the association among MTHFR C677T, homocysteine levels and WMH, approached, but did not reach, signi fi cance (expected OR=1.75; 95% CI, 0.90 − 3.41; observed OR=1.68; 95% CI, 0.97 − 2.94). Neither CYP11B2 T( − 344)C nor MTHFR C677T were signi fi cantly associated when tested in a new independent cohort of 1202 patients with WMH. Conclusions There is a genetic basis to WMH but anonymous genome wide and exome studies are more likely to provide novel loci of interest.

[1]  Maja A. A. Binnewijzend,et al.  Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease , 2013, Neurobiology of Aging.

[2]  Kaitlin M. Fitzpatrick,et al.  17q25 Locus Is Associated With White Matter Hyperintensity Volume in Ischemic Stroke, But Not With Lacunar Stroke Status , 2013, Stroke.

[3]  A. Kondacs,et al.  Evaluation of the MTHFR A1298C Variant in Leukoaraiosis , 2012, Journal of Molecular Neuroscience.

[4]  Basil Grueter,et al.  Age-related cerebral white matter disease (leukoaraiosis): a review , 2011, Postgraduate Medical Journal.

[5]  A. Pavlovic,et al.  Increased total homocysteine level is associated with clinical status and severity of white matter changes in symptomatic patients with subcortical small vessel disease , 2011, Clinical Neurology and Neurosurgery.

[6]  P. Schofield,et al.  The Genetics of White Matter Lesions , 2011, CNS neuroscience & therapeutics.

[7]  M. Fornage,et al.  Genome‐wide association studies of cerebral white matter lesion burden , 2011, Annals of neurology.

[8]  H. Soininen,et al.  Changes in Vascular Risk Factors from Midlife to Late Life and White Matter Lesions: A 20-Year Follow-Up Study , 2011, Dementia and Geriatric Cognitive Disorders.

[9]  Eric E. Smith,et al.  White matter hyperintensity volume is increased in small vessel stroke subtypes , 2010, Neurology.

[10]  André G. Uitterlinden,et al.  Genetic variation in homocysteine metabolism, cognition, and white matter lesions , 2010, Neurobiology of Aging.

[11]  H. Markus,et al.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[12]  Eric E. Smith,et al.  Determinants of white matter hyperintensity volume in patients with acute ischemic stroke. , 2010, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[13]  W. Taylor,et al.  Influence of the MTHFR C677T polymorphism on magnetic resonance imaging hyperintensity volume and cognition in geriatric depression. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[14]  B. Mazoyer,et al.  Apolipoprotein E Genotype Is Related to Progression of White Matter Lesion Load , 2009, Stroke.

[15]  C. Anderson,et al.  Severe Cerebral White Matter Hyperintensities Predict Severe Cognitive Decline in Patients With Cerebrovascular Disease History , 2009, Stroke.

[16]  C. Sudlow,et al.  Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects , 2009, Stroke.

[17]  H. Urbach,et al.  Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma. , 2009, Neuro-oncology.

[18]  P. Scheltens,et al.  The renin-angiotensin-aldosterone system in cerebral small vessel disease , 2008, Journal of Neurology.

[19]  Stephan Züchner,et al.  The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[20]  A. Karantanas,et al.  Paraoxonase 1 gene polymorphisms in patients with osteonecrosis of the femoral head with and without cerebral white matter lesions , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[21]  P. Ridker,et al.  Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease. , 2007, The American journal of cardiology.

[22]  V. Thijs,et al.  Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds. , 2007, Stroke.

[23]  Z. Szolnoki Pathomechanism of leukoaraiosis , 2007, NeuroMolecular Medicine.

[24]  H. Markus,et al.  Polymorphisms in Genes of the Renin-Angiotensin System and Cerebral Small Vessel Disease , 2006, Cerebrovascular Diseases.

[25]  V. Mok,et al.  Apolipoprotein E ɛ4 allele is associated with the volume of white matter changes in patients with lacunar infarcts , 2006 .

[26]  Y. W. Chen,et al.  Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy , 2006, Neurology.

[27]  J. Growdon,et al.  Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. , 2006, Neurology.

[28]  M. Mascalchi,et al.  Alzheimer’s Disease: Role of Size and Location of White Matter Changes in Determining Cognitive Deficits , 2005, Dementia and Geriatric Cognitive Disorders.

[29]  M. V. van Boxtel,et al.  Associations of the Angiotensin II Type 1 Receptor A1166C and the Endothelial NO Synthase G894T Gene Polymorphisms With Silent Subcortical White Matter Lesions in Essential Hypertension , 2005, Stroke.

[30]  A. Hofman,et al.  ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala , 2005, Neurobiology of Aging.

[31]  C. DeCarli,et al.  Total Homocysteine Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study , 2005, Stroke.

[32]  S. Ebrahim,et al.  What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? , 2005, BMJ : British Medical Journal.

[33]  L. Smeeth,et al.  For Personal Use. Only Reproduce with Permission from Elsevier Ltd Homocysteine and Stroke: Evidence on a Causal Link from Mendelian Randomisation , 2022 .

[34]  S. Greenberg,et al.  White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage , 2004, Neurology.

[35]  Charles DeCarli,et al.  Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.

[36]  Charles DeCarli,et al.  Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.

[37]  Jan Cees de Groot,et al.  Interaction Between Hypertension, apoE, and Cerebral White Matter Lesions , 2004, Stroke.

[38]  A. Kondacs,et al.  Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis , 2004, Acta neurologica Scandinavica.

[39]  P. Sham,et al.  Endothelial Nitric Oxide Gene Haplotypes and Risk of Cerebral Small-Vessel Disease , 2004, Stroke.

[40]  M. Fornage,et al.  Heritability of Leukoaraiosis in Hypertensive Sibships , 2004, Hypertension.

[41]  K. Yoshikawa,et al.  Renin-angiotensin system gene polymorphism in Japanese stroke patients , 2003 .

[42]  K. Kohara,et al.  MTHFR Gene Polymorphism as a Risk Factor for Silent Brain Infarcts and White Matter Lesions in the Japanese General Population: The NILS-LSA Study , 2003, Stroke.

[43]  C. Dufouil,et al.  Influence of education on the relationship between white matter lesions and cognition , 2003, Neurology.

[44]  L. Kuller [Risk factors for dementia in the Cardiovascular Health Study cognition study]. , 2003, Revista de neurologia.

[45]  D. Wald,et al.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis , 2002, BMJ : British Medical Journal.

[46]  A. Smith,et al.  Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. , 2002, Archives of neurology.

[47]  J. Bamford,et al.  Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes , 2002, Journal of neurology, neurosurgery, and psychiatry.

[48]  A. de la Sierra,et al.  Renin-Angiotensin System Genetic Polymorphisms and Cerebral White Matter Lesions in Essential Hypertension , 2002, Hypertension.

[49]  M. Senaratne,et al.  Possible ethnic differences in plasma homocysteine levels associated with coronary artery disease between south asian and east asian immigrants , 2001, Clinical cardiology.

[50]  F. Fazekas,et al.  Angiotensinogen Polymorphism M235T, Carotid Atherosclerosis, and Small-Vessel Disease-Related Cerebral Abnormalities , 2001, Hypertension.

[51]  C. Reynolds,et al.  Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. , 2001, The American journal of psychiatry.

[52]  J. Guàrdia,et al.  MRI and genetic correlates of cognitive function in elders with memory impairment , 2001, Neurobiology of Aging.

[53]  E Auffray,et al.  Longitudinal study of blood pressure and white matter hyperintensities , 2001, Neurology.

[54]  F. Cambien,et al.  Aldosterone synthase (CYP11B2) gene polymorphism and cerebral white matter hyperintensities , 2001, Neurology.

[55]  J M Wardlaw,et al.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: the Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[56]  S. Yusuf,et al.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) , 2000, The Lancet.

[57]  F. Fazekas,et al.  MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms : three-year follow-up of the austrian stroke prevention study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[58]  H. Kawakami,et al.  Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[59]  P. Wolf,et al.  The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[60]  E. Mori,et al.  Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. , 2000, Stroke.

[61]  R. Doody,et al.  Does APO epsilon4 correlate with MRI changes in Alzheimer's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.

[62]  C. Azen,et al.  Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities. , 1999, The American journal of clinical nutrition.

[63]  D. Easton,et al.  Apolipoprotein E Genetic Variation and Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.

[64]  C. DeCarli,et al.  Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. , 1999, Stroke.

[65]  Z. Janka,et al.  Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population , 1998, Acta neurologica Scandinavica.

[66]  G. Wilcock,et al.  Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population , 1998, International journal of geriatric psychiatry.

[67]  B L Miller,et al.  Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.

[68]  K. Blennow,et al.  A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality , 1998, Journal of neurology, neurosurgery, and psychiatry.

[69]  C. Broeckhoven,et al.  Dutch hereditary cerebral amyloid angiopathy: Structural lesions and apolipoprotein E genotype , 1997, Annals of neurology.

[70]  F. Fazekas,et al.  Apolipoprotein E4allele in the normal elderly: neuropsychologic and brain MRI correlates , 1996, Clinical genetics.

[71]  J. Pruvo,et al.  Risk factors and leukoaraiosis in stroke patients , 1996, Acta neurologica Scandinavica.

[72]  S. Gauthier,et al.  Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.

[73]  AllanJ. Fox,et al.  LEUKOARAIOSIS , 1989, The Lancet.